Zealand Pharma (ZEAL) AGM 2023 summary

Opening remarks and agenda

• AGM held partly electronically on March 29, 2023; the meeting acknowledged management’s report on the prior financial year and approved the 2022 audited annual report.

Financial performance review

• 2022 financial result was a loss of TDKK 1,202,135, carried forward to the next financial year.

Board and executive committee updates

• All incumbent directors were re-elected; Martin Nicklasson continued as Chair and Kirsten Aarup Drejer as Vice-Chair.

• Audit Committee: Martin Nicklasson, Leonard Kruimer, Bernadette Mary Connaughton and Jeffrey Berkowitz; Kruimer continued as Chair.

• Remuneration Committee: Nicklasson, Michael J. Owen and Alain Munoz, chaired by Nicklasson; Scientific Committee: Drejer, Munoz and Owen, chaired by Drejer.